583 related articles for article (PubMed ID: 1349424)
21. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis.
Rothstein JD; Van Kammen M; Levey AI; Martin LJ; Kuncl RW
Ann Neurol; 1995 Jul; 38(1):73-84. PubMed ID: 7611729
[TBL] [Abstract][Full Text] [Related]
22. Synaptosomal glutamate and GABA transport in patients with temporal lobe epilepsy.
Hoogland G; Spierenburg HA; van Veelen CW; van Rijen PC; van Huffelen AC; de Graan PN
J Neurosci Res; 2004 Jun; 76(6):881-90. PubMed ID: 15160399
[TBL] [Abstract][Full Text] [Related]
23. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons.
Mu X; He J; Anderson DW; Trojanowski JQ; Springer JE
Ann Neurol; 1996 Sep; 40(3):379-86. PubMed ID: 8797527
[TBL] [Abstract][Full Text] [Related]
24. Ganglioside patterns in amyotrophic lateral sclerosis brain regions.
Rapport MM; Donnenfeld H; Brunner W; Hungund B; Bartfeld H
Ann Neurol; 1985 Jul; 18(1):60-7. PubMed ID: 4037752
[TBL] [Abstract][Full Text] [Related]
25. Examining the interaction of apo E and neurotoxicity on a murine model of ALS-PDC.
Wilson JM; Petrik MS; Moghadasian MH; Shaw CA
Can J Physiol Pharmacol; 2005 Feb; 83(2):131-41. PubMed ID: 15791286
[TBL] [Abstract][Full Text] [Related]
26. Activation of gamma-aminobutyric acid GAT-1 transporters on glutamatergic terminals of mouse spinal cord mediates glutamate release through anion channels and by transporter reversal.
Raiteri L; Stigliani S; Patti L; Usai C; Bucci G; Diaspro A; Raiteri M; Bonanno G
J Neurosci Res; 2005 May; 80(3):424-33. PubMed ID: 15789377
[TBL] [Abstract][Full Text] [Related]
27. Trace element imbalances in amyotrophic lateral sclerosis.
Khare SS; Ehmann WD; Kasarskis EJ; Markesbery WR
Neurotoxicology; 1990; 11(3):521-32. PubMed ID: 2284056
[TBL] [Abstract][Full Text] [Related]
28. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
Rothstein JD
Adv Neurol; 1995; 68():7-20; discussion 21-7. PubMed ID: 8787245
[TBL] [Abstract][Full Text] [Related]
29. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients.
Shibata N; Kakita A; Takahashi H; Ihara Y; Nobukuni K; Fujimura H; Sakoda S; Sasaki S; Iwata M; Morikawa S; Hirano A; Kobayashi M
Neurodegener Dis; 2009; 6(3):118-26. PubMed ID: 19372705
[TBL] [Abstract][Full Text] [Related]
30. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex.
Bristol LA; Rothstein JD
Ann Neurol; 1996 May; 39(5):676-9. PubMed ID: 8619555
[TBL] [Abstract][Full Text] [Related]
31. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis.
Rothstein JD; Tsai G; Kuncl RW; Clawson L; Cornblath DR; Drachman DB; Pestronk A; Stauch BL; Coyle JT
Ann Neurol; 1990 Jul; 28(1):18-25. PubMed ID: 2375630
[TBL] [Abstract][Full Text] [Related]
32. Glutamate uptake is decreased tardively in the spinal cord of FALS mice.
Canton T; Pratt J; Stutzmann JM; Imperato A; Boireau A
Neuroreport; 1998 Mar; 9(5):775-8. PubMed ID: 9579663
[TBL] [Abstract][Full Text] [Related]
33. Rethinking a drug treatment failure on a traditional ALS target.
Maragakis NJ
Exp Neurol; 2009 Apr; 216(2):254-7. PubMed ID: 19309797
[TBL] [Abstract][Full Text] [Related]
34. Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA).
Sasabe J; Aiso S
Chem Biodivers; 2010 Jun; 7(6):1479-90. PubMed ID: 20564566
[TBL] [Abstract][Full Text] [Related]
35. Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups.
Medina L; Figueredo-Cardenas G; Rothstein JD; Reiner A
Exp Neurol; 1996 Dec; 142(2):287-95. PubMed ID: 8934560
[TBL] [Abstract][Full Text] [Related]
36. Potential treatment of amyotrophic lateral sclerosis with gabapentin: a hypothesis.
Welty DF; Schielke GP; Rothstein JD
Ann Pharmacother; 1995 Nov; 29(11):1164-7. PubMed ID: 8573965
[TBL] [Abstract][Full Text] [Related]
37. Altered metabolism of excitatory amino acids, N-acetyl-aspartate and N-acetyl-aspartyl-glutamate in amyotrophic lateral sclerosis.
Plaitakis A; Constantakakis E
Brain Res Bull; 1993; 30(3-4):381-6. PubMed ID: 8457887
[TBL] [Abstract][Full Text] [Related]
38. Synaptosomal glutamate uptake declines progressively in the spinal cord of a mutant mouse with motor neuron disease.
Battaglioli G; Martin DL; Plummer J; Messer A
J Neurochem; 1993 Apr; 60(4):1567-9. PubMed ID: 8095977
[TBL] [Abstract][Full Text] [Related]
39. [Neurotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis patients against some enzymes of glutamate metabolism].
Niebroj-Dobosz I; Janik P; Mickielewicz A; Jamrozik Z; Kwieciński H
Neurol Neurochir Pol; 2001; 35(1 Suppl):81-9. PubMed ID: 11732283
[TBL] [Abstract][Full Text] [Related]
40. [MR imaging of amyotrophic lateral sclerosis].
Oba H; Araki T; Monzawa S; Onishi H; Toyama K; Kachi K; Nogata Y; Ohtomo K; Koizumi K; Uchiyama G
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 Apr; 52(4):427-35. PubMed ID: 1630888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
